Publications by authors named "Haneen Saker"
Background: Diagnosis of interstitial lung disease (ILD) is based on multidisciplinary team discussion (MDD) with the incorporation of clinical, radiographical, and histopathologic information if available. We aim to evaluate the diagnostic yield and safety outcomes of transbronchial lung cryobiopsy (TBLC) in the diagnosis of ILD.
Methods: We conducted a meta-analysis by comprehensive literature search to include all studies that evaluated the diagnostic yields and/or adverse events with TBLC in patients with ILD.
Article Synopsis
- Recent studies indicate an uptick in the use of immune checkpoint inhibitors (ICIs) in advanced cancer patients nearing the end of life, but detailed understanding of this trend is limited.
- A chart review of 97 patients who received ICIs in their last 30 days revealed that 40% received only one dose, with many having a poor performance status and high hospitalization rates.
- The findings suggest that while ICIs may offer potential benefits, careful consideration of factors like performance status and patient wishes is crucial for oncologists when making treatment decisions at the end of life.
Neuroendocrine tumours occur most frequently in the gastrointestinal tract, lungs, and pancreas. Primary malignant cardiac tumours are uncommon and are usually sarcomas, lymphomas, or, infrequently, mesotheliomas. Primary cardiac neuroendocrine carcinomas are exceedingly rare; only nine have been reported in the literature to date.
View Article and Find Full Text PDFGenetic testing has a potential in the prevention of genetic diseases, particularly in communities with high rates of consanguineous marriage. Therefore, knowledge, practice, and attitudes of the public in Jordan regarding genetic testing were investigated. Individuals (N = 3,196) were questioned about the concepts of genetic testing and genetic counselors, if they underwent any genetic tests, the type of test, the method of consenting to the test, as well as their level of satisfaction with the privacy of the genetic testing service.
View Article and Find Full Text PDF